Nabriva Therapeutics plc Stock Price, News & Analysis
Company Description
Nabriva Therapeutics plc (NASDAQ: NBRV) is a publicly traded medicinal and botanical manufacturing company in the Manufacturing sector. The company has a market capitalization of $4.5M.
NBRV stock has declined 78.2% over the past year.
This page provides a comprehensive overview of NBRV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nabriva Therapeutics plc (NBRV) stock. Over the past 12 months, the stock has lost 78.2%. At a market capitalization of $4.5M, NBRV is classified as a micro-cap stock.
Latest News
Nabriva Therapeutics plc has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include clinical trial, earnings, conferences, stock split. View all NBRV news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
NBRV Company Profile & Sector Positioning
Nabriva Therapeutics plc (NBRV) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.